Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Immunogenicity and Safety of the Second Dose of Varicella Vaccine in Healthy Children: An Open-label Study

NCT07475000 is registered in ClinicalTrials.gov with Sinovac (Dalian) Vaccine Technology Co., Ltd. as lead sponsor.

NCT NCT07475000
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07475000 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Immunogenicity and Safety of the Second Dose of Varicella Vaccine in Healthy Children: An Open-label Study
Lead sponsor
Sinovac (Dalian) Vaccine Technology Co., Ltd.
Phase
Phase 3
Overall status
Recruiting
Start date
January 28, 2026
Completion date
November 15, 2026
Enrollment
300 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

varicella (chickenpox), varicella immunisation